Jushi Holdings (JUSHF) Profit After Tax (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Profit After Tax came in at -$19.8 million in Q1 2026, down 16.64% year-on-year from -$23.8 million in Q1 2025, and down 27.58% on a QoQ basis from -$15.6 million in Q4 2025.
Jushi Holdings (JUSHF) Profit After Tax (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Profit After Tax data on file, last reported at -$19.8 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 16.64% year-over-year to -$19.8 million in Q1 2026; TTM through Mar 2026 was -$71.4 million, a 50.56% decrease from a year earlier, with the FY2025 full-year figure at -$68.6 million, down 40.62% from the prior year.
- Profit After Tax for Q1 2026 stood at -$19.8 million, down from -$15.6 million in the prior quarter.
- Over the last five years, Profit After Tax for JUSHF reached as high as $12.1 million in Q2 2022 and fell as low as -$139.9 million in Q4 2022.
- Historically, Profit After Tax has averaged -$23.8 million across 5 years, with a median of -$17.0 million in 2025.
- On a YoY basis, Profit After Tax climbed as much as 357.74% in 2022 and fell as far as 2519.38% in 2022.
- Year by year, Profit After Tax stood at -$139.9 million in 2022, then surged by 87.13% to -$18.0 million in 2023, then surged by 30.75% to -$12.5 million in 2024, then retreated by 24.77% to -$15.6 million in 2025, then fell by 27.58% to -$19.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$19.8 million in Q1 2026, -$15.6 million in Q4 2025, and -$23.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | -19.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.85 Mn |
| Dec 31, 2025 | -15.56 Mn |
| Sep 30, 2025 | -23.69 Mn |
| Jun 30, 2025 | -12.33 Mn |
| Mar 31, 2025 | -17.02 Mn |
| Dec 31, 2024 | -12.47 Mn |
| Sep 30, 2024 | -16.02 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -18.36 Mn |
| Dec 31, 2023 | -18.00 Mn |
| Sep 30, 2023 | -20.62 Mn |
| Jun 30, 2023 | -14.04 Mn |
| Mar 31, 2023 | -12.44 Mn |
| Dec 31, 2022 | -139.94 Mn |
| Sep 30, 2022 | -54.70 Mn |
| Jun 30, 2022 | 12.07 Mn |
| Mar 31, 2022 | -19.76 Mn |
| Dec 31, 2021 | 5.78 Mn |
| Sep 30, 2021 | 39.74 Mn |
| Jun 30, 2021 | 2.64 Mn |